

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.60870113 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.60870113 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.54684562 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.48725605 |
| 5 | negative T cell selection (GO:0043383) | 4.00207044 |
| 6 | negative thymic T cell selection (GO:0045060) | 3.96467482 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.87268098 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 3.82584785 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.77453065 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.77453065 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 3.77453065 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 3.77453065 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 3.77453065 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.77453065 |
| 15 | response to interleukin-15 (GO:0070672) | 3.75801954 |
| 16 | negative regulation of T cell mediated immunity (GO:0002710) | 3.71598090 |
| 17 | tolerance induction (GO:0002507) | 3.68685129 |
| 18 | cellular extravasation (GO:0045123) | 3.68477399 |
| 19 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.67508513 |
| 20 | substrate-dependent cell migration (GO:0006929) | 3.66996675 |
| 21 | response to peptidoglycan (GO:0032494) | 3.56848469 |
| 22 | myeloid dendritic cell differentiation (GO:0043011) | 3.55645910 |
| 23 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.50023559 |
| 24 | T cell migration (GO:0072678) | 3.49686630 |
| 25 | regulation of T cell tolerance induction (GO:0002664) | 3.48816537 |
| 26 | positive regulation of granulocyte differentiation (GO:0030854) | 3.46191791 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39308987 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 3.38967907 |
| 29 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.37674624 |
| 30 | regulation of B cell differentiation (GO:0045577) | 3.36617084 |
| 31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.35725408 |
| 32 | establishment of endothelial barrier (GO:0061028) | 3.34081265 |
| 33 | myeloid dendritic cell activation (GO:0001773) | 3.32254854 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.31496951 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 3.29718244 |
| 36 | B cell receptor signaling pathway (GO:0050853) | 3.29479927 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.27324309 |
| 38 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.24686092 |
| 39 | cellular response to interleukin-15 (GO:0071350) | 3.22678143 |
| 40 | leukocyte aggregation (GO:0070486) | 3.21235562 |
| 41 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.19097453 |
| 42 | detection of other organism (GO:0098543) | 3.18743856 |
| 43 | NIK/NF-kappaB signaling (GO:0038061) | 3.17767722 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 3.17229866 |
| 45 | positive thymic T cell selection (GO:0045059) | 3.14250440 |
| 46 | myeloid cell activation involved in immune response (GO:0002275) | 3.13824999 |
| 47 | interferon-gamma production (GO:0032609) | 3.13551163 |
| 48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12812436 |
| 49 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.12797218 |
| 50 | endothelial tube morphogenesis (GO:0061154) | 3.11585944 |
| 51 | morphogenesis of an endothelium (GO:0003159) | 3.11585944 |
| 52 | thymic T cell selection (GO:0045061) | 3.10784923 |
| 53 | activated T cell proliferation (GO:0050798) | 3.09621673 |
| 54 | mast cell activation (GO:0045576) | 3.07849881 |
| 55 | regulation of regulatory T cell differentiation (GO:0045589) | 3.05288472 |
| 56 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.04561428 |
| 57 | T cell selection (GO:0045058) | 3.02673646 |
| 58 | immunoglobulin mediated immune response (GO:0016064) | 3.00641158 |
| 59 | detection of molecule of bacterial origin (GO:0032490) | 2.95217784 |
| 60 | detection of bacterium (GO:0016045) | 2.95074849 |
| 61 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.92144413 |
| 62 | negative regulation of cell killing (GO:0031342) | 2.92144413 |
| 63 | cell adhesion mediated by integrin (GO:0033627) | 2.91998758 |
| 64 | angiogenesis involved in wound healing (GO:0060055) | 2.91386833 |
| 65 | leukocyte degranulation (GO:0043299) | 2.91225237 |
| 66 | positive regulation of macrophage differentiation (GO:0045651) | 2.88531506 |
| 67 | leukocyte cell-cell adhesion (GO:0007159) | 2.88143447 |
| 68 | lymph vessel development (GO:0001945) | 2.87770614 |
| 69 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.86935144 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.86651069 |
| 71 | surfactant homeostasis (GO:0043129) | 2.86609617 |
| 72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86536470 |
| 73 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.85981310 |
| 74 | detection of external biotic stimulus (GO:0098581) | 2.84703978 |
| 75 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.84031266 |
| 76 | response to type I interferon (GO:0034340) | 2.83939824 |
| 77 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83828755 |
| 78 | positive regulation of interleukin-2 production (GO:0032743) | 2.82727771 |
| 79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.81402062 |
| 80 | T cell costimulation (GO:0031295) | 2.78256162 |
| 81 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.78198058 |
| 82 | granulocyte activation (GO:0036230) | 2.77418775 |
| 83 | T cell homeostasis (GO:0043029) | 2.76217187 |
| 84 | positive regulation of isotype switching (GO:0045830) | 2.75702814 |
| 85 | type I interferon signaling pathway (GO:0060337) | 2.73914392 |
| 86 | cellular response to type I interferon (GO:0071357) | 2.73914392 |
| 87 | lymphocyte costimulation (GO:0031294) | 2.72018899 |
| 88 | natural killer cell differentiation (GO:0001779) | 2.71327321 |
| 89 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.69324489 |
| 90 | positive T cell selection (GO:0043368) | 2.69004346 |
| 91 | natural killer cell activation (GO:0030101) | 2.68788300 |
| 92 | dendritic cell differentiation (GO:0097028) | 2.68205943 |
| 93 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.67781066 |
| 94 | regulation of granulocyte differentiation (GO:0030852) | 2.67369054 |
| 95 | regulation of tolerance induction (GO:0002643) | 2.66460571 |
| 96 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65035022 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.64446675 |
| 98 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.64446675 |
| 99 | positive regulation of lamellipodium assembly (GO:0010592) | 2.63992818 |
| 100 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.63477496 |
| 101 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.63477496 |
| 102 | regulation of alpha-beta T cell activation (GO:0046634) | 2.63155602 |
| 103 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.62240202 |
| 104 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.61923172 |
| 105 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.61902136 |
| 106 | myeloid leukocyte activation (GO:0002274) | 2.60985349 |
| 107 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.60851801 |
| 108 | regulation of necroptotic process (GO:0060544) | 2.60645982 |
| 109 | heterotypic cell-cell adhesion (GO:0034113) | 2.59811955 |
| 110 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.59210604 |
| 111 | positive regulation of B cell mediated immunity (GO:0002714) | 2.59210604 |
| 112 | microglial cell activation (GO:0001774) | 2.58239653 |
| 113 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.58211691 |
| 114 | positive regulation of vasculogenesis (GO:2001214) | 2.57265667 |
| 115 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.56904285 |
| 116 | defense response to protozoan (GO:0042832) | 2.56538420 |
| 117 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.55675567 |
| 118 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.55675567 |
| 119 | leukocyte tethering or rolling (GO:0050901) | 2.55587274 |
| 120 | lymph node development (GO:0048535) | 2.54612252 |
| 121 | regulation of T-helper cell differentiation (GO:0045622) | 2.54272706 |
| 122 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.50459135 |
| 123 | regulation of T-helper 1 type immune response (GO:0002825) | 2.50434765 |
| 124 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.50373866 |
| 125 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.48800833 |
| 126 | sprouting angiogenesis (GO:0002040) | 2.48112300 |
| 127 | T cell proliferation (GO:0042098) | 2.47865818 |
| 128 | positive regulation of antigen processing and presentation (GO:0002579) | 2.46281351 |
| 129 | positive regulation of tolerance induction (GO:0002645) | 2.46060515 |
| 130 | membrane raft organization (GO:0031579) | 2.45954514 |
| 131 | lymphocyte homeostasis (GO:0002260) | 2.45815944 |
| 132 | growth hormone receptor signaling pathway (GO:0060396) | 2.44776361 |
| 133 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.44478534 |
| 134 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.40880687 |
| 135 | B cell homeostasis (GO:0001782) | 2.40729460 |
| 136 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.39518670 |
| 137 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.39198108 |
| 138 | neutrophil activation (GO:0042119) | 2.38417785 |
| 139 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.37931805 |
| 140 | neutrophil activation involved in immune response (GO:0002283) | 2.37747218 |
| 141 | T cell receptor signaling pathway (GO:0050852) | 2.36230045 |
| 142 | germinal center formation (GO:0002467) | 2.35398666 |
| 143 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.32964024 |
| 144 | embryonic hemopoiesis (GO:0035162) | 2.32954947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.86618915 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.28832351 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.07874719 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.07473441 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.71620607 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.64959223 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.22380946 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.19951916 |
| 9 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.19340824 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.01917545 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.99543632 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.87277381 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86810064 |
| 14 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.70811899 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.48938241 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.46250819 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.43581767 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41672049 |
| 19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.39681592 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32665338 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.32659470 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23439378 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.21477897 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.19078747 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.10498238 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.03323271 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95415107 |
| 28 | * MYB_26560356_Chip-Seq_TH1_Human | 1.89802709 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84610279 |
| 30 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.82807792 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73748534 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.73582667 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.73018022 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71431239 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70273528 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.69812119 |
| 37 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.66822349 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61551078 |
| 39 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.59482670 |
| 40 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.57887961 |
| 41 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.52453627 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51161649 |
| 43 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.50076853 |
| 44 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49791298 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.49415193 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.47744601 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46260890 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.45805038 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43509394 |
| 50 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.43328190 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42044337 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40441868 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40187118 |
| 54 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.38156981 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37350511 |
| 56 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.32395749 |
| 57 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.32243396 |
| 58 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.32243396 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28695703 |
| 60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.28220666 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28081268 |
| 62 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27146889 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26521636 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24998876 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20625794 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18968600 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17142168 |
| 68 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16053650 |
| 69 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15956631 |
| 70 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15542198 |
| 71 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15227952 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14823974 |
| 73 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14131288 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12338168 |
| 75 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.12203235 |
| 76 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10756412 |
| 77 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09629798 |
| 78 | * MAF_26560356_Chip-Seq_TH2_Human | 1.09404632 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09189680 |
| 80 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08461932 |
| 81 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07240714 |
| 82 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07094343 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06577115 |
| 84 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04111364 |
| 85 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03990137 |
| 86 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03868486 |
| 87 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02763089 |
| 88 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01408130 |
| 89 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00777717 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99036314 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98035513 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97408846 |
| 93 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95740321 |
| 94 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94493121 |
| 95 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94056757 |
| 96 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94056757 |
| 97 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93935410 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93667335 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92367578 |
| 100 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92262089 |
| 101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92105098 |
| 102 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92026895 |
| 103 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91397273 |
| 104 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91011952 |
| 105 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90172353 |
| 106 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90153810 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89184591 |
| 108 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.88269985 |
| 109 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84436790 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84363739 |
| 111 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84188732 |
| 112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.83353383 |
| 113 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83172338 |
| 114 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82590862 |
| 115 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.81061788 |
| 116 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79894233 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77371407 |
| 118 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.76417414 |
| 119 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76106856 |
| 120 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.73051593 |
| 121 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72973897 |
| 122 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72446011 |
| 123 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.70991521 |
| 124 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70362847 |
| 125 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.69927283 |
| 126 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.69638315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 3.06689317 |
| 2 | MP0004510_myositis | 2.94610655 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.93700490 |
| 4 | MP0005671_abnormal_response_to | 2.88392017 |
| 5 | MP0010368_abnormal_lymphatic_system | 2.70148938 |
| 6 | MP0001790_abnormal_immune_system | 2.64242780 |
| 7 | MP0005387_immune_system_phenotype | 2.64242780 |
| 8 | MP0003303_peritoneal_inflammation | 2.64101902 |
| 9 | MP0003724_increased_susceptibility_to | 2.59207489 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.48853547 |
| 11 | MP0001879_abnormal_lymphatic_vessel | 2.46418021 |
| 12 | MP0009785_altered_susceptibility_to | 2.39813475 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.29335142 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.26405832 |
| 15 | MP0001800_abnormal_humoral_immune | 2.21304717 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.18514770 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.13975375 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.11223456 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.05563934 |
| 20 | MP0002006_tumorigenesis | 2.04617304 |
| 21 | MP0003436_decreased_susceptibility_to | 2.04022111 |
| 22 | MP0004808_abnormal_hematopoietic_stem | 2.01177850 |
| 23 | MP0002723_abnormal_immune_serum | 1.99110906 |
| 24 | MP0002420_abnormal_adaptive_immunity | 1.97080564 |
| 25 | MP0001819_abnormal_immune_cell | 1.96954876 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.96666578 |
| 27 | MP0004272_abnormal_basement_membrane | 1.95135669 |
| 28 | MP0009278_abnormal_bone_marrow | 1.94441570 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 1.94207816 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.94207816 |
| 31 | MP0005025_abnormal_response_to | 1.92366878 |
| 32 | MP0003279_aneurysm | 1.88134611 |
| 33 | MP0002398_abnormal_bone_marrow | 1.87395840 |
| 34 | MP0002405_respiratory_system_inflammati | 1.86910698 |
| 35 | MP0003828_pulmonary_edema | 1.83827808 |
| 36 | MP0001873_stomach_inflammation | 1.81142915 |
| 37 | MP0005451_abnormal_body_composition | 1.80593235 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.80119058 |
| 39 | MP0006054_spinal_hemorrhage | 1.72378229 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.70363591 |
| 41 | MP0003091_abnormal_cell_migration | 1.69808383 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.69077056 |
| 43 | MP0002419_abnormal_innate_immunity | 1.68129545 |
| 44 | MP0000716_abnormal_immune_system | 1.65571922 |
| 45 | MP0003448_altered_tumor_morphology | 1.64800166 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.61525922 |
| 47 | MP0005623_abnormal_meninges_morphology | 1.56621223 |
| 48 | MP0004947_skin_inflammation | 1.46819080 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.46243825 |
| 50 | MP0002933_joint_inflammation | 1.42347753 |
| 51 | MP0002722_abnormal_immune_system | 1.41744915 |
| 52 | MP0001853_heart_inflammation | 1.41671919 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.40442991 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.40262191 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.39626023 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.39378400 |
| 57 | MP0002429_abnormal_blood_cell | 1.38608051 |
| 58 | MP0004381_abnormal_hair_follicle | 1.38316475 |
| 59 | MP0008260_abnormal_autophagy | 1.34616757 |
| 60 | MP0006082_CNS_inflammation | 1.34151767 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.33151484 |
| 62 | MP0001958_emphysema | 1.30903399 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.30516868 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.28734623 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.25244376 |
| 66 | MP0000767_abnormal_smooth_muscle | 1.24858006 |
| 67 | MP0008004_abnormal_stomach_pH | 1.23485467 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.21784417 |
| 69 | MP0004883_abnormal_blood_vessel | 1.19754767 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 1.18929398 |
| 71 | MP0000733_abnormal_muscle_development | 1.13584957 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.12459804 |
| 73 | MP0000015_abnormal_ear_pigmentation | 1.11270697 |
| 74 | MP0000343_altered_response_to | 1.09812721 |
| 75 | MP0000858_altered_metastatic_potential | 1.08664797 |
| 76 | MP0002877_abnormal_melanocyte_morpholog | 1.08652323 |
| 77 | MP0000465_gastrointestinal_hemorrhage | 1.08568418 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.08325776 |
| 79 | MP0005023_abnormal_wound_healing | 1.07609044 |
| 80 | MP0003045_fibrosis | 1.06734673 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.06569868 |
| 82 | MP0008438_abnormal_cutaneous_collagen | 1.04715286 |
| 83 | MP0000249_abnormal_blood_vessel | 1.04332099 |
| 84 | MP0008057_abnormal_DNA_replication | 1.03620826 |
| 85 | MP0004084_abnormal_cardiac_muscle | 1.03267088 |
| 86 | MP0001851_eye_inflammation | 1.02290789 |
| 87 | MP0008775_abnormal_heart_ventricle | 0.98515358 |
| 88 | MP0003075_altered_response_to | 0.96471359 |
| 89 | MP0005310_abnormal_salivary_gland | 0.96352291 |
| 90 | MP0005166_decreased_susceptibility_to | 0.95273887 |
| 91 | MP0002128_abnormal_blood_circulation | 0.94582323 |
| 92 | MP0003866_abnormal_defecation | 0.93541459 |
| 93 | MP0002925_abnormal_cardiovascular_devel | 0.93155931 |
| 94 | MP0003943_abnormal_hepatobiliary_system | 0.90485897 |
| 95 | MP0000604_amyloidosis | 0.88406880 |
| 96 | MP0002009_preneoplasia | 0.84871082 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 0.84690123 |
| 98 | MP0009764_decreased_sensitivity_to | 0.82875464 |
| 99 | MP0010630_abnormal_cardiac_muscle | 0.78586034 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.77938402 |
| 101 | MP0001614_abnormal_blood_vessel | 0.77669182 |
| 102 | MP0005165_increased_susceptibility_to | 0.77496371 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.76101759 |
| 104 | MP0009763_increased_sensitivity_to | 0.75995200 |
| 105 | MP0008469_abnormal_protein_level | 0.72643449 |
| 106 | MP0003795_abnormal_bone_structure | 0.71162752 |
| 107 | MP0000490_abnormal_crypts_of | 0.70135657 |
| 108 | MP0005390_skeleton_phenotype | 0.69786828 |
| 109 | MP0004484_altered_response_of | 0.69385624 |
| 110 | MP0002295_abnormal_pulmonary_circulatio | 0.69216042 |
| 111 | MP0006138_congestive_heart_failure | 0.68615295 |
| 112 | MP0005164_abnormal_response_to | 0.67880341 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.66648868 |
| 114 | MP0004147_increased_porphyrin_level | 0.66553228 |
| 115 | MP0004130_abnormal_muscle_cell | 0.66548744 |
| 116 | MP0003690_abnormal_glial_cell | 0.65916164 |
| 117 | MP0009115_abnormal_fat_cell | 0.65861962 |
| 118 | MP0002019_abnormal_tumor_incidence | 0.65735793 |
| 119 | MP0010307_abnormal_tumor_latency | 0.65274627 |
| 120 | MP0001663_abnormal_digestive_system | 0.62566611 |
| 121 | MP0005385_cardiovascular_system_phenoty | 0.62279523 |
| 122 | MP0001544_abnormal_cardiovascular_syste | 0.62279523 |
| 123 | MP0005409_darkened_coat_color | 0.61964762 |
| 124 | MP0001915_intracranial_hemorrhage | 0.61193332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Interstitial pulmonary disease (HP:0006530) | 3.88943699 |
| 2 | Chronic otitis media (HP:0000389) | 3.80228989 |
| 3 | Spontaneous hematomas (HP:0007420) | 3.57403445 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.41960837 |
| 5 | Abnormality of the nasal mucosa (HP:0000433) | 3.40367801 |
| 6 | Hematochezia (HP:0002573) | 3.38161744 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.34781422 |
| 8 | Myositis (HP:0100614) | 3.31454742 |
| 9 | Autoimmune hemolytic anemia (HP:0001890) | 3.22943922 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 3.21486031 |
| 11 | Recurrent viral infections (HP:0004429) | 3.19187347 |
| 12 | T lymphocytopenia (HP:0005403) | 3.16505432 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.14145237 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.06068611 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.03026345 |
| 16 | Gingivitis (HP:0000230) | 3.02778630 |
| 17 | Recurrent bronchitis (HP:0002837) | 2.95448268 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 2.90536162 |
| 19 | Nasal polyposis (HP:0100582) | 2.88955654 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 2.87375350 |
| 21 | Polycythemia (HP:0001901) | 2.85721414 |
| 22 | Cellulitis (HP:0100658) | 2.71709229 |
| 23 | Granulocytopenia (HP:0001913) | 2.64578102 |
| 24 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.64558240 |
| 25 | Osteolytic defects of the hand bones (HP:0009699) | 2.64558240 |
| 26 | Aortic aneurysm (HP:0004942) | 2.63797957 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 2.62890549 |
| 28 | Encephalitis (HP:0002383) | 2.59813858 |
| 29 | Increased density of long bones (HP:0006392) | 2.56230409 |
| 30 | Keratoconjunctivitis (HP:0001096) | 2.55407408 |
| 31 | Optic neuritis (HP:0100653) | 2.55140786 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 2.55140786 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53856257 |
| 34 | Abnormality of the fingertips (HP:0001211) | 2.52519581 |
| 35 | Cerebral aneurysm (HP:0004944) | 2.52239832 |
| 36 | Orchitis (HP:0100796) | 2.51385058 |
| 37 | Abnormality of T cells (HP:0002843) | 2.47076383 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.42720867 |
| 39 | Colitis (HP:0002583) | 2.38222920 |
| 40 | Gingival bleeding (HP:0000225) | 2.38143716 |
| 41 | Increased IgE level (HP:0003212) | 2.37797549 |
| 42 | Vasculitis (HP:0002633) | 2.37643929 |
| 43 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.37581286 |
| 44 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.37581286 |
| 45 | Abnormality of glycolipid metabolism (HP:0010969) | 2.37581286 |
| 46 | Panhypogammaglobulinemia (HP:0003139) | 2.36517910 |
| 47 | Porencephaly (HP:0002132) | 2.35935012 |
| 48 | Spondylolisthesis (HP:0003302) | 2.35006150 |
| 49 | Arterial thrombosis (HP:0004420) | 2.34927567 |
| 50 | Stomatitis (HP:0010280) | 2.30979958 |
| 51 | Meningitis (HP:0001287) | 2.29036796 |
| 52 | Aortic dissection (HP:0002647) | 2.28650048 |
| 53 | Increased IgM level (HP:0003496) | 2.26534804 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.26392680 |
| 55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23018328 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23018328 |
| 57 | Chronic diarrhea (HP:0002028) | 2.22571398 |
| 58 | Thick nail (HP:0001805) | 2.22257180 |
| 59 | Protrusio acetabuli (HP:0003179) | 2.20081606 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.19779716 |
| 61 | Prolonged bleeding time (HP:0003010) | 2.19547845 |
| 62 | Lymphopenia (HP:0001888) | 2.18803656 |
| 63 | Asymmetry of the thorax (HP:0001555) | 2.18036096 |
| 64 | Slow saccadic eye movements (HP:0000514) | 2.17229330 |
| 65 | Acute myeloid leukemia (HP:0004808) | 2.16780725 |
| 66 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.16369925 |
| 67 | Urticaria (HP:0001025) | 2.15756729 |
| 68 | Osteomyelitis (HP:0002754) | 2.14363852 |
| 69 | Pulmonary embolism (HP:0002204) | 2.13706606 |
| 70 | IgA deficiency (HP:0002720) | 2.13569886 |
| 71 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13253262 |
| 72 | Syringomyelia (HP:0003396) | 2.12543165 |
| 73 | Spinal cord lesions (HP:0100561) | 2.12543165 |
| 74 | Dilatation of the ascending aorta (HP:0005111) | 2.12371658 |
| 75 | Recurrent bacterial skin infections (HP:0005406) | 2.11806023 |
| 76 | Eosinophilia (HP:0001880) | 2.07781720 |
| 77 | Papilloma (HP:0012740) | 2.07475120 |
| 78 | Verrucae (HP:0200043) | 2.07475120 |
| 79 | Esophageal varix (HP:0002040) | 2.07144279 |
| 80 | Abnormality of macrophages (HP:0004311) | 2.05993908 |
| 81 | Combined immunodeficiency (HP:0005387) | 2.05913396 |
| 82 | Subacute progressive viral hepatitis (HP:0006572) | 2.04845685 |
| 83 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.04669315 |
| 84 | Pustule (HP:0200039) | 2.03809887 |
| 85 | Milia (HP:0001056) | 2.03462419 |
| 86 | Conjunctival telangiectasia (HP:0000524) | 2.02440886 |
| 87 | Skin ulcer (HP:0200042) | 2.01950242 |
| 88 | Glomerulopathy (HP:0100820) | 2.01138119 |
| 89 | Hemoptysis (HP:0002105) | 2.00727282 |
| 90 | Increased cerebral lipofuscin (HP:0011813) | 2.00380450 |
| 91 | Inflammation of the large intestine (HP:0002037) | 2.00017011 |
| 92 | Amaurosis fugax (HP:0100576) | 1.99444718 |
| 93 | Petechiae (HP:0000967) | 1.98783421 |
| 94 | Leukocytosis (HP:0001974) | 1.97189735 |
| 95 | Hypergammaglobulinemia (HP:0010702) | 1.95374096 |
| 96 | Abnormal platelet volume (HP:0011876) | 1.95243699 |
| 97 | Abnormality of the peritoneum (HP:0002585) | 1.91958165 |
| 98 | Gangrene (HP:0100758) | 1.91219227 |
| 99 | Bicuspid aortic valve (HP:0001647) | 1.90072704 |
| 100 | Amyloidosis (HP:0011034) | 1.89976149 |
| 101 | Chronic sinusitis (HP:0011109) | 1.89168827 |
| 102 | Gastrointestinal inflammation (HP:0004386) | 1.88543699 |
| 103 | Peritonitis (HP:0002586) | 1.86743160 |
| 104 | IgM deficiency (HP:0002850) | 1.86324676 |
| 105 | Thrombocytosis (HP:0001894) | 1.85954378 |
| 106 | Chronic obstructive pulmonary disease (HP:0006510) | 1.85102125 |
| 107 | Obstructive lung disease (HP:0006536) | 1.85102125 |
| 108 | Absent frontal sinuses (HP:0002688) | 1.84444808 |
| 109 | Dysostosis multiplex (HP:0000943) | 1.84294112 |
| 110 | Glucose intolerance (HP:0000833) | 1.84281689 |
| 111 | Adactyly (HP:0009776) | 1.84154976 |
| 112 | Persistence of primary teeth (HP:0006335) | 1.83690088 |
| 113 | Thyroiditis (HP:0100646) | 1.83036576 |
| 114 | Recurrent skin infections (HP:0001581) | 1.82089607 |
| 115 | Abnormality of the prostate (HP:0008775) | 1.81715592 |
| 116 | Vertebral compression fractures (HP:0002953) | 1.80657666 |
| 117 | Epistaxis (HP:0000421) | 1.79625237 |
| 118 | Emphysema (HP:0002097) | 1.79242803 |
| 119 | Broad face (HP:0000283) | 1.79035559 |
| 120 | Abnormality of eosinophils (HP:0001879) | 1.78780086 |
| 121 | Abnormality of T cell physiology (HP:0011840) | 1.78092809 |
| 122 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.78039404 |
| 123 | Short 4th metacarpal (HP:0010044) | 1.78039404 |
| 124 | Chest pain (HP:0100749) | 1.77320265 |
| 125 | Joint swelling (HP:0001386) | 1.76330362 |
| 126 | Acrocyanosis (HP:0001063) | 1.74541783 |
| 127 | Pulmonary artery stenosis (HP:0004415) | 1.74316463 |
| 128 | Nonimmune hydrops fetalis (HP:0001790) | 1.73823243 |
| 129 | Fatigue (HP:0012378) | 1.73551084 |
| 130 | Periodontitis (HP:0000704) | 1.73397065 |
| 131 | Increased mean platelet volume (HP:0011877) | 1.72794960 |
| 132 | Abnormality of B cell number (HP:0010975) | 1.72711475 |
| 133 | B lymphocytopenia (HP:0010976) | 1.72711475 |
| 134 | IgG deficiency (HP:0004315) | 1.72642689 |
| 135 | Severe combined immunodeficiency (HP:0004430) | 1.72562781 |
| 136 | Vertebral arch anomaly (HP:0008438) | 1.72555638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 3.92741504 |
| 2 | MAP4K1 | 3.59579934 |
| 3 | JAK3 | 3.14677194 |
| 4 | PRPF4B | 3.10564348 |
| 5 | TIE1 | 3.00330927 |
| 6 | MAP3K14 | 2.98556178 |
| 7 | TXK | 2.80514522 |
| 8 | STK10 | 2.75379134 |
| 9 | TYK2 | 2.40753690 |
| 10 | TBK1 | 2.19048697 |
| 11 | JAK1 | 2.15469614 |
| 12 | LRRK2 | 2.07975236 |
| 13 | ZAP70 | 2.04167449 |
| 14 | EPHB1 | 1.94860281 |
| 15 | TGFBR2 | 1.93374256 |
| 16 | IKBKE | 1.85658210 |
| 17 | RIPK1 | 1.80508942 |
| 18 | FGFR3 | 1.79996944 |
| 19 | ITK | 1.79563147 |
| 20 | NLK | 1.72574648 |
| 21 | DMPK | 1.67969454 |
| 22 | KIT | 1.64133541 |
| 23 | TAOK3 | 1.61633380 |
| 24 | CAMKK2 | 1.60496976 |
| 25 | TGFBR1 | 1.56876222 |
| 26 | BMPR2 | 1.54608711 |
| 27 | TEC | 1.53678544 |
| 28 | PIM2 | 1.51452099 |
| 29 | PIK3CG | 1.50258002 |
| 30 | TTN | 1.48296104 |
| 31 | IKBKB | 1.46183448 |
| 32 | MST4 | 1.44835495 |
| 33 | MAP3K10 | 1.42129022 |
| 34 | CSK | 1.39413162 |
| 35 | FGFR4 | 1.35856789 |
| 36 | STK24 | 1.27607365 |
| 37 | NEK9 | 1.25750127 |
| 38 | CHUK | 1.24658035 |
| 39 | TRIB3 | 1.24074976 |
| 40 | LCK | 1.19528012 |
| 41 | SIK3 | 1.19143907 |
| 42 | IRAK3 | 1.18004739 |
| 43 | PTK2B | 1.17047581 |
| 44 | MAP3K3 | 1.16104036 |
| 45 | MAP3K13 | 1.13140684 |
| 46 | MARK3 | 1.12700595 |
| 47 | PKN2 | 1.12217674 |
| 48 | PIM1 | 1.11037686 |
| 49 | TRPM7 | 1.10331656 |
| 50 | BTK | 1.08048469 |
| 51 | HCK | 1.06658880 |
| 52 | SYK | 1.06392260 |
| 53 | EPHA3 | 1.06068463 |
| 54 | EEF2K | 1.05736347 |
| 55 | GRK7 | 1.01644374 |
| 56 | PTK6 | 1.01324544 |
| 57 | FGR | 0.99319646 |
| 58 | ERN1 | 0.99259748 |
| 59 | MAP3K1 | 0.98974949 |
| 60 | CDK12 | 0.96757345 |
| 61 | TAOK2 | 0.94884572 |
| 62 | PRKCQ | 0.94173113 |
| 63 | MOS | 0.91892069 |
| 64 | RPS6KA4 | 0.90624430 |
| 65 | CLK1 | 0.90454188 |
| 66 | MAPK7 | 0.88324424 |
| 67 | KSR2 | 0.86115049 |
| 68 | PRKCH | 0.86049632 |
| 69 | PRKG2 | 0.84250129 |
| 70 | SCYL2 | 0.80505986 |
| 71 | CDK6 | 0.80449167 |
| 72 | CAMKK1 | 0.78423168 |
| 73 | JAK2 | 0.77423444 |
| 74 | PDGFRB | 0.75667686 |
| 75 | FLT3 | 0.75015603 |
| 76 | PASK | 0.73660013 |
| 77 | BRD4 | 0.71559307 |
| 78 | BLK | 0.70549485 |
| 79 | STK4 | 0.70477570 |
| 80 | FES | 0.69852410 |
| 81 | GRK6 | 0.69844530 |
| 82 | SIK2 | 0.69530783 |
| 83 | EGFR | 0.66681942 |
| 84 | BMX | 0.64704454 |
| 85 | PTK2 | 0.62939349 |
| 86 | YES1 | 0.61582654 |
| 87 | STK3 | 0.60860425 |
| 88 | CSF1R | 0.57194119 |
| 89 | MAP3K6 | 0.56950012 |
| 90 | MAPKAPK2 | 0.56087392 |
| 91 | MATK | 0.55989092 |
| 92 | MAP2K3 | 0.55744822 |
| 93 | IRAK1 | 0.55110358 |
| 94 | TNK2 | 0.54582789 |
| 95 | MAPK11 | 0.53813581 |
| 96 | ILK | 0.53750535 |
| 97 | MAP3K7 | 0.53084374 |
| 98 | PDPK1 | 0.53074298 |
| 99 | MAP3K2 | 0.52201716 |
| 100 | RET | 0.51910371 |
| 101 | PAK4 | 0.51738081 |
| 102 | LYN | 0.51629298 |
| 103 | MARK2 | 0.50340350 |
| 104 | IRAK4 | 0.49497942 |
| 105 | SMG1 | 0.48536080 |
| 106 | MAP3K12 | 0.47617466 |
| 107 | IGF1R | 0.46975624 |
| 108 | STK38 | 0.45590716 |
| 109 | BRSK2 | 0.44197037 |
| 110 | TYRO3 | 0.43888898 |
| 111 | INSR | 0.43600622 |
| 112 | CDC42BPA | 0.43016324 |
| 113 | MYLK | 0.42543641 |
| 114 | SGK3 | 0.42467390 |
| 115 | TAOK1 | 0.42332936 |
| 116 | MAPK12 | 0.42204456 |
| 117 | MELK | 0.41961496 |
| 118 | WNK1 | 0.40046466 |
| 119 | SRC | 0.39248634 |
| 120 | MAP3K5 | 0.38703155 |
| 121 | NME2 | 0.37681009 |
| 122 | RPS6KL1 | 0.37450499 |
| 123 | RPS6KC1 | 0.37450499 |
| 124 | ROCK2 | 0.36935171 |
| 125 | ABL1 | 0.36478677 |
| 126 | CAMK4 | 0.35664673 |
| 127 | PRKD2 | 0.35502180 |
| 128 | CDK4 | 0.34025605 |
| 129 | MAP3K11 | 0.33821032 |
| 130 | FGFR2 | 0.33697055 |
| 131 | ALK | 0.33462288 |
| 132 | RIPK4 | 0.33083812 |
| 133 | PDGFRA | 0.32751556 |
| 134 | MAPK4 | 0.31485494 |
| 135 | FYN | 0.30885136 |
| 136 | PAK2 | 0.30240219 |
| 137 | PDK1 | 0.28637897 |
| 138 | HIPK2 | 0.27245602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 2.27460127 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.15827371 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11078535 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05437774 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.03100352 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00856093 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.98735919 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.93655564 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 1.93185568 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79414291 |
| 11 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77915906 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73622273 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66464433 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.65857965 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.64440670 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59133118 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59044391 |
| 18 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.56959509 |
| 19 | Shigellosis_Homo sapiens_hsa05131 | 1.56498165 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55278248 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.53881465 |
| 22 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.53102951 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.50768456 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50157130 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50020543 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.46802913 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.40930308 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35236494 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33514328 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33002861 |
| 31 | Focal adhesion_Homo sapiens_hsa04510 | 1.30135205 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.29354153 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27923039 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.27734604 |
| 35 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.26412785 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.26162215 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24995857 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22947136 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.21717835 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.20546990 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.17844075 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16978661 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16931093 |
| 44 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14876605 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.13700513 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.13603081 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.12729919 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06084647 |
| 49 | Adherens junction_Homo sapiens_hsa04520 | 1.04558300 |
| 50 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.03264806 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.02525651 |
| 52 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.02474108 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.99719251 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98092794 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98004238 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.97909801 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97293961 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95573542 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.95361087 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94978741 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94759426 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94460868 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91448097 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88827414 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.88251283 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88006790 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86347779 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86204614 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86000927 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.84307965 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84088682 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81790282 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80718662 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79892558 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79747430 |
| 76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.79532132 |
| 77 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.77191319 |
| 78 | Pathways in cancer_Homo sapiens_hsa05200 | 0.76923820 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.73238022 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72482808 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.72100174 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70577457 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70310680 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69601466 |
| 85 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69288610 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.68250943 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67494865 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66263850 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.65962768 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65749354 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65075922 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.65054656 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64820128 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64025225 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61435037 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61112905 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60723423 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56832199 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56636346 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56080317 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54433631 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54004348 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52433846 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.52384379 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52210047 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51399813 |
| 107 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47988786 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47701985 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47509223 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44757107 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44342296 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43683971 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.42848284 |
| 114 | Melanoma_Homo sapiens_hsa05218 | 0.42674700 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.40933771 |

